ÿþ<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><html><head> <!--link href="../master.css" rel="stylesheet" type="text/css"--></head> <body bgcolor="#EAE9E9"><font face="verdana"> <table width="530" height="700" cellpadding="0" cellspacing="10" bgcolor="#EAE9E9"><tr valign="top"><td><h2 class="PageContent">Development Faculty</h2></td></tr> <tr><td> <b><i>Program Chair</i></b><br> <b>Howard Fillit, MD</b><br> Clinical Professor of Geriatrics and Medicine<br /> Professor of Neurobiology<br> The Mount Sinai School of Medicine<br> Executive Director<br> The Alzheimer's Drug Discovery Foundation<br> Institute for the Study of Aging<br> New York, New York<br> <br> Howard Fillit, MD, has been a consultant, grantee, or received honoraria from Eisai Inc.; Elan Pharmaceuticals, Inc.; Forest Laboratories, Inc.; Neurochem Inc.; Novartis Pharmaceuticals Corp.; Eli Lilly and Company; Ortho-McNeil Pharmaceutical, Inc.; Pfizer Inc; and sanofi-aventis U.S.<br /><br /> </td></tr> <tr><td> <b><i>CME Reviewer</i></b><br> <b>Gregory Volturo, MD</b><br> Professor of Emergency Medicine<br> University of Massachusetts Medical School<br> Vice Chairman, Emergency Medicine<br> University of Massachusetts Memorial<br />&nbsp;&nbsp;&nbsp;Health Care University Campus<br> Worcester, Massachusetts<br> <br> Gregory Volturo, MD, has no actual or potential conflicts of interest in relation to this program/presentation<br /><br /> </td></tr> <tr><td> <b>Committee/Staff Disclosures:</b><br> The following CME program planners have indicated their financial interests and/or relationships with commercial manufacturer(s) (and/or those of their spouse/partner) below. Planners with no relevant financial relationships are listed with N/A.<br><br> Denise Leary, has no actual or potential conflicts of interest in relation to this program/presentation. <br /> Sapana Panday, has no actual or potential conflicts of interest in relation to this program/presentation.<br /><br /> </td></tr> </table></font></body></html>